COVID-19 Agency Policy, Guidance and Resources
University of Kentucky Protein Core
Agency for HealthCare Research and Quality (AHRQ)
- AHRQ Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
(NOT-HS-21-002) - Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations
Centers for Disease Control and Prevention
Department of Defense
- DoD - Defense Logistics Agency Reporting Coronavirus Impacts To Defense Logistics Agency (DLA)
- DoD Office of Assistant Secretary for Preparedness and Response REQUEST A USG CORONAWATCH MEETING
Department of Energy
- ARPA-E: Important Updates to Funding Opportunities, Projects & Programs due to COVID-19
- COVID-19 DOE Implementation of OMB Memorandum M-20-17
Department of Health and Human Services
Health Resources and Services Administration
- COVID-19 Grantee Frequently Asked Questions
- Coronavirus Disease (COVID-19) Frequently Asked Questions – Federal Office of Rural Health Policy
National Aeronautics and Space Administration
National Endowment for the Arts
National Endowment for the Humanities
National Institutes of Health
- Temporary Extension of Eligibility for the NIDDK K01 Mentored Research Scientist Development Award During the COVID-19 Pandemic (NOT-DK-20-054)
- Temporary Extension of Applicant Eligibility in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
- Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
- Notice to Extend Eligibility for Submission to PAR-19-371, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) due to COVID-related Disruptions
- Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
- Notice to Extend Eligibility for Submission of Diversity K22 Applications due to COVID–related Disruptions
- Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency
- NIH - Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
- Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
- NIH – Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19)
- NICHD Late Application Policy for Institutional Training Grants to RFA-HD-21-014 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)
- NIA Late Application Policy for NIA-Specific FOAs with Application Due Dates in May, June, and July 2020
- NIDCR Announces Availability of Frequently Asked Questions (FAQs) for Coronavirus Disease 2019 (COVID-19)-Related Notices of Special Interest (NOSI) NOT-DE-20-022 and NOT-DE-20-023
- NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)
- NCI -Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
- Temporary, Emergency Situations Due to COVID-19 and Application Scores Received During Peer Review
- Can ESI Status Be Extended Due to Disruptions From COVID-19?
- General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19
- NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19)
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
- NIH - Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
- Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
- NHLBI Announces Availability of Frequently Asked Questions (FAQs) for NOT-HL-20-757, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
National Institute of Food and Agriculture
In addition to the announcement on NIFA’s home page, updates are also on the following pages:
- NIFA’s AFRI resource page
- NIFA’s AFRI Deadline page
- NIFA’s Plan of Work page
- NIFA’s POW and REEport Integration
- NIFA 15-016 Late Application Consideration
- NIFA Deadline Extensions Due to COVID-19
National Science Foundation
Foundations
- Alzheimer's Drug Discovery Foundation FAQS: COVID-19 AND ADDF RESEARCH RESOURCES
- Gates, Wellcome, and Mastercard: Initiative to Speed Development and Access to Therapies for COVID-19
- Chan Zuckerberg Foundation: Compilation of Resources on Scientific research on COVID-19
- Sloan Foundation: Notice to Grantees
- Spencer Foundation: Notice to Community
- John Templeton Foundation: Message to Grantees and Applicants
- William T. Grant Foundation: Message to Grantees
- Windgate Foundation: Message to Grantees
- PCORI: Responses to Frequently Asked Questions Related to COVID-19
- The Michael J. Fox Foundation FAQs: Coronavirus (COVID-19) & Research Support